AMBS under a dime has substantially more upside than GTHP at .40 which was the conversion price of the recent warrants.
MNKD is overvalued.
Read the recent Yahoo news about Amarantus Bioscience.
p.s. Dr. Joseph Rubinfeld, one of the co-founders of Amgen, is on $AMBS's advisory board.